342 related articles for article (PubMed ID: 18794899)
1. E2F1 represses beta-catenin transcription and is antagonized by both pRB and CDK8.
Morris EJ; Ji JY; Yang F; Di Stefano L; Herr A; Moon NS; Kwon EJ; Haigis KM; Näär AM; Dyson NJ
Nature; 2008 Sep; 455(7212):552-6. PubMed ID: 18794899
[TBL] [Abstract][Full Text] [Related]
2. Lycopene synergistically enhances quinacrine action to inhibit Wnt-TCF signaling in breast cancer cells through APC.
Preet R; Mohapatra P; Das D; Satapathy SR; Choudhuri T; Wyatt MD; Kundu CN
Carcinogenesis; 2013 Feb; 34(2):277-86. PubMed ID: 23129580
[TBL] [Abstract][Full Text] [Related]
3. Cancer: Entangled pathways.
Bernards R
Nature; 2008 Sep; 455(7212):479-80. PubMed ID: 18818647
[No Abstract] [Full Text] [Related]
4. CDK8 regulates E2F1 transcriptional activity through S375 phosphorylation.
Zhao J; Ramos R; Demma M
Oncogene; 2013 Jul; 32(30):3520-30. PubMed ID: 22945643
[TBL] [Abstract][Full Text] [Related]
5. E2F1 suppresses Wnt/β-catenin activity through transactivation of β-catenin interacting protein ICAT.
Wu Z; Zheng S; Li Z; Tan J; Yu Q
Oncogene; 2011 Sep; 30(37):3979-84. PubMed ID: 21532622
[TBL] [Abstract][Full Text] [Related]
6. Galangin suppresses the proliferation of β-catenin response transcription-positive cancer cells by promoting adenomatous polyposis coli/Axin/glycogen synthase kinase-3β-independent β-catenin degradation.
Gwak J; Oh J; Cho M; Bae SK; Song IS; Liu KH; Jeong Y; Kim DE; Chung YH; Oh S
Mol Pharmacol; 2011 Jun; 79(6):1014-22. PubMed ID: 21406604
[TBL] [Abstract][Full Text] [Related]
7. Sox17 and Sox4 differentially regulate beta-catenin/T-cell factor activity and proliferation of colon carcinoma cells.
Sinner D; Kordich JJ; Spence JR; Opoka R; Rankin S; Lin SC; Jonatan D; Zorn AM; Wells JM
Mol Cell Biol; 2007 Nov; 27(22):7802-15. PubMed ID: 17875931
[TBL] [Abstract][Full Text] [Related]
8. Activation of AXIN2 expression by beta-catenin-T cell factor. A feedback repressor pathway regulating Wnt signaling.
Leung JY; Kolligs FT; Wu R; Zhai Y; Kuick R; Hanash S; Cho KR; Fearon ER
J Biol Chem; 2002 Jun; 277(24):21657-65. PubMed ID: 11940574
[TBL] [Abstract][Full Text] [Related]
9. e2f1 Gene is a new member of Wnt/beta-catenin/Tcf-regulated genes.
Abramova MV; Zatulovskiy EA; Svetlikova SB; Kukushkin AN; Pospelov VA
Biochem Biophys Res Commun; 2010 Jan; 391(1):142-6. PubMed ID: 19900401
[TBL] [Abstract][Full Text] [Related]
10. Adenomatous polyposis coli regulates endothelial cell migration independent of roles in beta-catenin signaling and cell-cell adhesion.
Harris ES; Nelson WJ
Mol Biol Cell; 2010 Aug; 21(15):2611-23. PubMed ID: 20519433
[TBL] [Abstract][Full Text] [Related]
11. Lysophosphatidic acid activates β-catenin/T cell factor signaling, which contributes to the suppression of apoptosis in H19-7 cells.
Sun Y; Kim NH; Ji L; Kim SH; Lee J; Rhee HJ
Mol Med Rep; 2013 Dec; 8(6):1729-33. PubMed ID: 24145616
[TBL] [Abstract][Full Text] [Related]
12. Activation of the canonical Wnt/beta-catenin pathway confers growth advantages in c-Myc/E2F1 transgenic mouse model of liver cancer.
Calvisi DF; Conner EA; Ladu S; Lemmer ER; Factor VM; Thorgeirsson SS
J Hepatol; 2005 Jun; 42(6):842-9. PubMed ID: 15885355
[TBL] [Abstract][Full Text] [Related]
13. E2F1 represses beta-catenin/TCF activity by direct up-regulation of Siah1.
Xie W; Jin L; Mei Y; Wu M
J Cell Mol Med; 2009 Aug; 13(8B):1719-1727. PubMed ID: 20187294
[TBL] [Abstract][Full Text] [Related]
14. Chromosomal instability by beta-catenin/TCF transcription in APC or beta-catenin mutant cells.
Aoki K; Aoki M; Sugai M; Harada N; Miyoshi H; Tsukamoto T; Mizoshita T; Tatematsu M; Seno H; Chiba T; Oshima M; Hsieh CL; Taketo MM
Oncogene; 2007 May; 26(24):3511-20. PubMed ID: 17160019
[TBL] [Abstract][Full Text] [Related]
15. H19 Noncoding RNA, an Independent Prognostic Factor, Regulates Essential Rb-E2F and CDK8-β-Catenin Signaling in Colorectal Cancer.
Ohtsuka M; Ling H; Ivan C; Pichler M; Matsushita D; Goblirsch M; Stiegelbauer V; Shigeyasu K; Zhang X; Chen M; Vidhu F; Bartholomeusz GA; Toiyama Y; Kusunoki M; Doki Y; Mori M; Song S; Gunther JR; Krishnan S; Slaby O; Goel A; Ajani JA; Radovich M; Calin GA
EBioMedicine; 2016 Nov; 13():113-124. PubMed ID: 27789274
[TBL] [Abstract][Full Text] [Related]
16. [Mechanism of Wnt signaling pathway regulation by a truncated mutant of Axin2 in colorectal cancer].
Wang FW; Wen L; Zhu SW; Yao Q; Cai YM; Ma G
Ai Zheng; 2007 Oct; 26(10):1041-6. PubMed ID: 17927870
[TBL] [Abstract][Full Text] [Related]
17. Regulation of human nitric oxide synthase 2 expression by Wnt beta-catenin signaling.
Du Q; Park KS; Guo Z; He P; Nagashima M; Shao L; Sahai R; Geller DA; Hussain SP
Cancer Res; 2006 Jul; 66(14):7024-31. PubMed ID: 16849547
[TBL] [Abstract][Full Text] [Related]
18. Low-grade slightly elevated and polypoid colorectal adenomas display differential β-catenin-TCF/LEF activity, c-Myc, and cyclin D1 expression.
Yang TW; Gao YH; Ma SY; Wu Q; Li ZF
World J Gastroenterol; 2017 May; 23(17):3066-3076. PubMed ID: 28533663
[TBL] [Abstract][Full Text] [Related]
19. The β-catenin/TCF complex as a novel target of resveratrol in the Wnt/β-catenin signaling pathway.
Chen HJ; Hsu LS; Shia YT; Lin MW; Lin CM
Biochem Pharmacol; 2012 Nov; 84(9):1143-53. PubMed ID: 22935447
[TBL] [Abstract][Full Text] [Related]
20. A dynamic exchange of TCF3 and TCF4 transcription factors controls MYC expression in colorectal cancer cells.
Shah M; Rennoll SA; Raup-Konsavage WM; Yochum GS
Cell Cycle; 2015; 14(3):323-32. PubMed ID: 25659031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
